Tunek A[au] - Search Results

Year	Number of Results
1977	1
1978	1
1979	4
1980	3
1981	4
1982	1
1983	1
1988	4
1989	3
1990	3
1991	2
1993	1
1994	2
1995	1
1997	1
1998	3
1999	1
2007	1
2012	2
2015	1
2022	0

1

Pharmacologic importance of the reversible fatty acid conjugation of budesonide studied in a rat cell line In vitro.

Wieslander E, Delander EL, Järkelid L, Hjertberg E, Tunek A, Brattsand R. Wieslander E, et al. Among authors: tunek a. Am J Respir Cell Mol Biol. 1998 Sep;19(3):477-84. doi: 10.1165/ajrcmb.19.3.3195. Am J Respir Cell Mol Biol. 1998. PMID: 9730876

2

The discovery of a selective and potent A2a agonist with extended lung retention.

Åstrand AB, Lamm Bergström E, Zhang H, Börjesson L, Söderdahl T, Wingren C, Jansson AH, Smailagic A, Johansson C, Bladh H, Shamovsky I, Tunek A, Drmota T. Åstrand AB, et al. Among authors: tunek a. Pharmacol Res Perspect. 2015 Jun;3(3):e00134. doi: 10.1002/prp2.134. Epub 2015 May 4. Pharmacol Res Perspect. 2015. PMID: 26236482 Free PMC article.

3

The right compound in the right assay at the right time: an integrated discovery DMPK strategy.

Ballard P, Brassil P, Bui KH, Dolgos H, Petersson C, Tunek A, Webborn PJ. Ballard P, et al. Among authors: tunek a. Drug Metab Rev. 2012 Aug;44(3):224-52. doi: 10.3109/03602532.2012.691099. Epub 2012 Jun 15. Drug Metab Rev. 2012. PMID: 22697420 Review.

4

The design and bioactivation of presystemically stable prodrugs.

Svensson LA, Tunek A. Svensson LA, et al. Among authors: tunek a. Drug Metab Rev. 1988;19(2):165-94. doi: 10.3109/03602538809049622. Drug Metab Rev. 1988. PMID: 3069421 Review. No abstract available.

5

High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.

Wan H, Rehngren M, Giordanetto F, Bergström F, Tunek A. Wan H, et al. Among authors: tunek a. J Med Chem. 2007 Sep 20;50(19):4606-15. doi: 10.1021/jm070375w. Epub 2007 Aug 29. J Med Chem. 2007. PMID: 17725338

6

A rapid and sensitive method for determination of covalent binding of benzo[a]pyrene to proteins.

Wallin H, Schelin C, Tunek A, Jergil B. Wallin H, et al. Among authors: tunek a. Chem Biol Interact. 1981 Dec;38(1):109-18. doi: 10.1016/0009-2797(81)90157-5. Chem Biol Interact. 1981. PMID: 6173136

7

N-isobutyrylcysteine, a donor of systemic thiols, does not reduce the exacerbation rate in chronic bronchitis.

Ekberg-Jansson A, Larson M, MacNee W, Tunek A, Wahlgren L, Wouters EF, Larsson S. Ekberg-Jansson A, et al. Among authors: tunek a. Eur Respir J. 1999 Apr;13(4):829-34. doi: 10.1034/j.1399-3003.1999.13d22.x. Eur Respir J. 1999. PMID: 10362048 Free article. Clinical Trial.

8

Discovery of phosphoinositide 3-kinases (PI3K) p110β isoform inhibitor 4-[2-hydroxyethyl(1-naphthylmethyl)amino]-6-[(2S)-2-methylmorpholin-4-yl]-1H-pyrimidin-2-one, an effective antithrombotic agent without associated bleeding and insulin resistance.

Giordanetto F, Wållberg A, Ghosal S, Iliefski T, Cassel J, Yuan ZQ, von Wachenfeldt H, Andersen SM, Inghardt T, Tunek A, Nylander S. Giordanetto F, et al. Among authors: tunek a. Bioorg Med Chem Lett. 2012 Nov 1;22(21):6671-6. doi: 10.1016/j.bmcl.2012.08.102. Epub 2012 Sep 6. Bioorg Med Chem Lett. 2012. PMID: 23010262

9

Hydrolysis of 3H-bambuterol, a carbamate prodrug of terbutaline, in blood from humans and laboratory animals in vitro.

Tunek A, Levin E, Svensson LA. Tunek A, et al. Biochem Pharmacol. 1988 Oct 15;37(20):3867-76. doi: 10.1016/0006-2952(88)90068-8. Biochem Pharmacol. 1988. PMID: 3190733

10

Interactions of bambuterol with human serum cholinesterase of the genotypes EuEu (normal), EaEa (atypical) and EuEa.

Tunek A, Hjertberg E, Mogensen JV. Tunek A, et al. Biochem Pharmacol. 1991 Feb 1;41(3):345-8. doi: 10.1016/0006-2952(91)90530-i. Biochem Pharmacol. 1991. PMID: 1994894

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results